Rotavirus is the most common cause of gastroenteritis. He is responsible for non-hospital and hospital gastrointestinal infections. It is a major epidemiological threat especially in the pediatric population. Acute diarrhea and dehydration cause 2 million hospitalizations and cause deaths of around 440,000 children annually. Rotavirus is also one of the most common aetiological factors of nosocomial infections in pediatric wards. The incidence of hospital RV infections ranges from 2.5 to 7.9 per 1000 days of hospitalization. It extends the stay from 1.7 to 7 days depending on the country [1,2,3,4]. Between 13 and 80% of children with RV infection require infusion therapy [1,2,5]. One of the most effective ways to reduce the incidence of RV infection is to immunize the body. There is evidence of the effectiveness of vaccination programs in both industrialized and developing countries [6]

diarhoea, rotawirus, nosocomial infection

Marinosci A, Doit C, Koehl B et al. Gastro-ente´rites nosocomiales a` rotavirus: e´tude re´trospective dans un service de pe´diatrie ge´ne´rale. Nosocomial rotavirus gastroenteritis. Archives de Pe´diatrie 2016;23:1118-1123

Nitsch-Osuch A, Kuchar E, Kosmala A, Życinska K, Wardyn K. Clinical research Nosocomial rotavirus gastroenterocolitis in a large tertiary paediatric hospital in Warsaw, 2006-2010. Arch Med Sci 2013; 9, 3: 493-498

Festini F, Cocchi P, Mambretti D et al. Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study. BMC Infectious Diseases 2010, 10: 235. http://www.biomedcentral.com/1471-2334/10/235 (27.07.2018)

Marc E, Biscardi S, Soulier M. Nosocomial rotavirus infections in a pediatric unit: surveillance during four successive winters. Médecine et maladies infectieuses 2007; 37: 61–66. http://france.elsevier.com/direct/MEDMAL/ - (25.07.2018)

Verhagen P, Moore D, Manges A, Quach C. Nosocomial rotavirus gastroenteritis in a Canadian paediatric hospital:incidence, disease burden and patients affected. Journal of Hospital Infection. 2011; 79: 59-63. www.elsevierhealth.com/journals/jhin - (29.07.2018).

Vesikari T, Matson DO, Dennehy P et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354:23-33.

Guarino A, Winter H, Sandhu B, Quak SH, Lanata C. Acute gastroenteritis disease: report of the FISPGHAN Working Group. J Pediatr Gastroenterol Nutr 2012;55(5):621–626.

Clark H, Marcello A, Lawley D, Reilly M, DiNubile MJ. Unexpectedly high burden of rotavirus gastroenteritis in very young infants. BMC Pediatr 2010;10:40–44.

Łoś-Rycharska E, Czerwionka-Szaflarska M. Biegunki rotawirusowe – dlaczego warto im zapobiegać. Przegląd Gastroenterologiczny 2011;6:60–68.

Van Damme P, Giaquinto C, Huet F, Gothefors L, Maxwell M, Van der WM. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004–2005: the REVEAL study. J Infect Dis 2007;195(Suppl. 1):4–16.

World Health Organization Rotavirus vaccines. WHO position paper - January 2013. Weekly Epidemiol Rec Health Sect Secr Leag Nations 2013; 88(5):49-64.

Payne DC, Wikswo M, Parashar UD. Manual for the surveillance of vaccine-preventable diseases. Chapter 13: Rotavirus. Cent Dis Control Prev Atlanta GA 2011; 1-11.

Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI: Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009, 200(Suppl 1):S9-S15.

Parashar UD, Gibson CJ, Bresse JS, Glass RI: Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006, 12(2):304-6.

Charles MD, Holman RC, Curns AT et al. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J 2006, 25(6):489-93.

Giaquinto C, van Damme P, REVEAL Study Group. Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL study. Scand J Infect Dis 2010;42: 142–147.

Patrzałek M, Patrzałek M.P. Zachorowania dzieci na biegunkę o etiologii Rotawirusowej z terenu Kielc i powiatu kieleckiego leczone w Wojewódzkim Specjalistycznym Szpitalu Dziecięcym w Kielcach w latach 2002-2006. Przegl Epidemiol. 2008; 62: 557-563.

Smok B, Zieniewicz-Cieślik K, Smukalska E, Pawłowska M. Acute diarrhoea inducted by rotavirus in children hospitalyzed in provincial hospital for infectious diseases in Bydgoszcz in 2014 year. Przegl Epidemiol. 2016;70(3): 462-470.

Gleizes O, Desselberger U, Tatochenko V. et al. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J 2006; 25:S12-21

Verstraeten T, van den Bosch W. Burden of rotavirus disease in the new European Union (poster). Presented at 23rd ESPID Congress, Valencia, Spain 2005.

Tichopád A, Müllerová J, Jackowska T. Cost Burdenof Severe Community-Acquired Rotavirus Gastroenteritis Requiring Hospitalizationin the Czech Republic, Slovakia, Poland, and Hungary: A Retrospective Patient Chart Review. Value in Health Regional Issues 2016; 10C: 53 – 60. www.elsevier.com/locate/vhri - (27.07.2018)

Stefcovicova M, Simurka P, Jurackova L et al. Nosocomial rotavirus gastroenterocolitis in pediatric department. Centr Eur J Publ Health 2008; 16: 12-6.

Posfay KM, Zerr DM, Pittet D. Infection control in pediatrics. Lancet Infect Dis 2008; 8: 19-31.

Phillips G, Lopman B, Rodrigues L, Tam CC. Asymptomatic rotavirus infections in England: prevalence, characteristics, and risk factors. Am J Epidemiol 2010;171:1023–1030.

Rheingans RD, Heylen J, Giaquinto C. Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense? Pediatr Infect Dis J 2006, 25(1 Suppl):S48-55.

Bagci S, Eis-Hübinger A, Yassin A et al. Clinical characteristics of viral intestinal infection in preterm and term neonates. Eur J Clin Microbiol Infect Dis 2010;29:1079–1084.

Kumagai H, Matsumoto S, Ebashi M, Ohsone T. Acute pancreatitis associated with rotavirus infection. Indian Pediatr 2009;46:1099–1101.

Shiiharaa T, Watanabea M, Honmaa A et al. Rotavirus associated acute encephalitis/ encephalopathy and concurrent cerebellitis: report of two cases. Brain Dev 2007;29:670–673.

Blanch A, Perel S, Acworth J. Paediatric intussusception: epidemiology and outcome. Emerg Med Austral 2007;19: 45–50.

Bernstein DI. Rotavirus overview. Pediatr Infect Dis J 2009; 28:S50-3; PMID:19252423; http://dx.doi.org/10.1097/INF.0b013e3181967bee

Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014. Vaccine. 2015; 33: 2097–2107. www.elsevier.com/locate/vaccine - (39.07.2018).

Parashar U. Uptake and impact of Rotavirus vaccines in U.S. children. 14th International Congress on Infectious Diseases; March 9-12, 2010; Miami

Vesikari T, Sutherland D, Jackson AE. Report of the ‘European Expert Meeting on Rotavirus Vaccination’, Tampere, Finland, 19-20 May 2009. Vaccine 2009; 27:7222-7.